دورية أكاديمية

Increased GS-II lectin binding and SATB2 downregulation are biological features for sessile serrated lesions and microvesicular hyperplastic polyps.

التفاصيل البيبلوغرافية
العنوان: Increased GS-II lectin binding and SATB2 downregulation are biological features for sessile serrated lesions and microvesicular hyperplastic polyps.
المؤلفون: Matoba H; Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, Japan., Iwaya M; Department of Laboratory Medicine and Pathology, Shinshu University Hospital, Matsumoto, Japan., Sato Y; Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, Japan., Kobayashi N; Department of Laboratory Medicine, JA North Alps Medical Center Azumi Hospital, Oaza-ikeda, Kitaazumi-gun, Japan., Takemura H; Department of Laboratory Medicine, JA North Alps Medical Center Azumi Hospital, Oaza-ikeda, Kitaazumi-gun, Japan., Kouno Y; Department of Pathology, Ina Central Hospital, Koshiroukubo, Ina, Japan., Karasawa A; Department of Pathology, Ina Central Hospital, Koshiroukubo, Ina, Japan., Nakayama J; Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, Japan.
المصدر: Pathology international [Pathol Int] 2023 Jun; Vol. 73 (6), pp. 246-254. Date of Electronic Publication: 2023 Apr 10.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Published by Blackwell Scientific Publications for the Japanese Society of Pathology Country of Publication: Australia NLM ID: 9431380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1827 (Electronic) Linking ISSN: 13205463 NLM ISO Abbreviation: Pathol Int Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Carlton South, Vic., Australia : Published by Blackwell Scientific Publications for the Japanese Society of Pathology, c1994-
مواضيع طبية MeSH: Colonic Polyps*/pathology , Adenoma*/pathology , Colorectal Neoplasms*/pathology , Matrix Attachment Region Binding Proteins*/metabolism, Humans ; Griffonia/metabolism ; Down-Regulation ; Goblet Cells/pathology ; Transcription Factors/metabolism
مستخلص: Sessile serrated lesions (SSLs) and microvesicular hyperplastic polyps (MVHPs) are colorectal lesions displaying gastric differentiation. Griffonia simplicifolia-II (GS-II) is a lectin specific to terminal α/βGlcNAc residues. Here, we assessed GS-II binding and performed immunostaining for HIK1083 (specific to terminal αGlcNAc residues), MUC5AC, MUC6, and special AT-rich sequence binding protein 2 (SATB2) in SSLs, MVHPs, and tubular adenomas (TAs). We observed MUC5AC positivity in 28 of 30 SSLs, but in only three of 23 TAs. Moreover, 24 of 30 SSLs were MUC6-positive, while none of the 23 TAs were MUC6-positive. None of the 30 SSLs or 23 TAs showed HIK1083 positivity. All 30 SSLs and 26 MVHPs were GS-II-positive, while only seven of 23 were in TAs. GS-II staining was mainly distributed in the Golgi region, but SSLs and MVHPs showed goblet cell distribution, in 20 of 30 and 19 of 26 cases, respectively. All SSLs, MVHPs, and TAs were SATB2-positive, but 21 of 30 SSLs and 12 of 26 MVHPs showed decreased staining intensity relative to adjacent mucosa, a decrease seen in only two of 23 in TAs. These results indicate overall that increased terminal βGlcNAc and decreased SATB2 expression are characteristics of SSLs and MVHPs.
(© 2023 The Authors. Pathology International published by Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.)
References: Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature Genet. 2006;38:787-93.
Kambara T, Simms LA, Whitehall VLJ, Spring KJ, Wynter CVA, Walsh MD, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut. 2004;53:1137-44.
Nosho K, Irahara N, Shima K, Kure S, Kirkner GJ, Schernhammer ES, et al. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One. 2008;3:e3698. https://doi.org/10.1371/journal.pone.0003698.
Qi Li W, Kawakami K, Ruszkiewicz A, Bennett G, Moore J, Iacopetta B. BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status. Mol Cancer. 2006;5:2. https://doi.org/10.1186/1476-4598-5-2.
Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, Murtaugh MA, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology. 2005;129:837-45.
Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 2011;42:1-10.
Hirono H, Ajioka Y, Watanabe H, Baba Y, Tozawa E, Nishikura K, et al. Bidirectional gastric differentiation in cellular mucin phenotype (foveolar and pyloric) in serrated adenoma and hyperplastic polyp of the colorectum. Pathol Int. 2004;54:401-7.
Mochizuka A, Uehara T, Nakamura T, Kobayashi Y, Ota H. Hyperplastic polyps and sessile serrated “adenomas” of the colon and rectum display gastric pyloric differentiation. Histochem Cell Biol. 2007;128:445-55.
Gibson JA, Hahn HP, Shahsafaei A, Odze RD. MUC expression in hyperplastic and serrated colonic polyps: lack of specificity of MUC6. Am J Surg Pathol. 2011;35:742-9.
Fujita K, Hirahashi M, Yamamoto H, Matsumoto T, Gushima M, Oda Y, et al. Mucin core protein expression in serrated polyps of the large intestine. Virchows Arch. 2010;457:443-9.
Walsh MD, Clendenning M, Williamson E, Pearson SA, Walters RJ, Nagler B, et al. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Mod Pathol. 2013;26:1642-56.
Iyer PNS, Wilkinson KD, Goldstein IJ. An N-acetyl-D-glucosamine binding lectin from Bandeiraea Simplicifolia seeds. Arch Biochem Biophys. 1976;177:330-33.
Nakayama J, Katsuyama T, Ono K, Honda T, Akamatsu T, Hattori H. Large bowel carcinoma-specific antigens detected by the lectin, Griffonia simplicifolia agglutinin-II. Jpn J Cancer Res (Gann). 1985;76:1078-84.
Ota H, Nakayama J, Katsuyama T, Kanai M. Histochemical comparison of specificity of three bowel carcinoma-reactive lectins, Griffonia simplicifolia agglutinin-II, peanut agglutinin and Ulex europaeus agglutinin-I. Acta Pathol Jpn. 1988;38:1547-59.
Dobreva G, Dambacher J, Grosschedl R. SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin μ gene expression. Genes Dev. 2003;17:3048-61.
FitzPatrick DR, Carr IM, McLaren L, Leek JP, Wightman P, Williamson K, et al. Identification of SATB2 as the cleft palate gene on 2q32-q33. Hum Mol Gen. 2003;12:2491-501.
Lin F, Shi J, Zhu S, Chen Z, Li A, Chen T, et al. Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine. Arch Pathol Lab Med. 2014;138:1015-26.
Magnusson K, De Wit M, Brennan DJ, Johnson LB, McGee SF, Lundberg E, et al. SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am J Surg Pathol. 2011;35:937-48.
Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT. SATB2 expression distinguishes ovarian metastases of colorectal and appendiceal origin from primary ovarian tumors of mucinous or endometrioid type. Am J Surg Pathol. 2016;40:419-32.
Ma C, Olevian DC, Lowenthal BM, Jayachandran P, Kozak MM, Chang DT, et al. Loss of SATB2 expression in colorectal carcinoma is associated with DNA mismatch repair protein deficiency and BRAF mutation. Am J Surg Pathol. 2018;42:1409-17.
Iwaya M, Ota H, Tateishi Y, Nakajima T, Riddell R, Conner JR. Colitis-associated colorectal adenocarcinomas are frequently associated with non-intestinal mucin profiles and loss of SATB2 expression. Mod Pathol. 2019;32:884-92.
Ma C, Henn P, Miller C, Herbst C, Hartman DJ, Pai RK. Loss of SATB2 expression is a biomarker of inflammatory bowel disease-associated colorectal dysplasia and adenocarcinoma. Am J Surg Pathol. 2019;43:1314-22.
WHO Classification of Tumours Editorial Board the WHO Classification of Tumours. Digestive system tumours. Volume 1. 5th ed. Geneva: World Health Organization; 2019. p. 163-73.
Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452-58.
Nakayama J, Okano A, Maeda H, Miyachi M, Ota H, Katsuyama T, et al. Griffonia simplicifolia agglutinin-2-binding glycoprotein as a novel carbohydrate antigen of human colonic carcinoma. Jpn J Cancer Res. 1990;81:388-95.
Larsson JMH, Karlsson H, Crespo JG, Johansson MEV, Eklund L, Sjövall H, et al. Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation. Inflamm Bowel Dis. 2011;17:2299-307.
Tatsumi N, Kushima R, Vieth M, Mukaisho K, Kakinoki R, Okabe H, et al. Cytokeratin 7/20 and mucin core protein expression in ulcerative colitis-associated colorectal neoplasms. Virchows Arch. 2006;448:756-62.
Varki A, Cummings RD, Esko JD, Stanley P, Hart GW. Essentials of glycobiology. 3rd ed. New York: Cold Spring Harbor Laboratory Press; 2017. p. 99-123.
Hisamatsu K, Noguchi K, Tomita H, Muto A, Yamada N, Kobayashi K, et al. Distinctive crypt shape in a sessile serrated adenoma/polyp: distribution of Ki67-, p16INK4a-, WNT5A-positive cells and intraepithelial lymphocytes. Oncol Rep. 2017;38:775-84.
Fortuna D, Boman B, O'Neill R, Palazzo J. MCM2 expression in serrated polyps demonstrates aberrant cellular proliferation. Hum Pathol. 2017;63:177-83.
Torlakovic EE, Gomez JD, Driman DK, Parfitt JR, Wang C, Benerjee T, et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol. 2008;32:21-9.
Kim JH, Kim KJ, Rhee YY, Bae JM, Cho NY, Lee HS, et al. Gastric-type expression signature in serrated pathway-associated colorectal tumors. Hum Pathol. 2015;46:643-56.
معلومات مُعتمدة: 19H03441 Japan Society for the Promotion of Science; 21K15400 Japan Society for the Promotion of Science
فهرسة مساهمة: Keywords: GS-II; SATB2; microvesicular hyperplastic polyps; sessile serrated lesions; βGlcNAc
المشرفين على المادة: 0 (SATB2 protein, human)
0 (Transcription Factors)
0 (Matrix Attachment Region Binding Proteins)
تواريخ الأحداث: Date Created: 20230410 Date Completed: 20230622 Latest Revision: 20230622
رمز التحديث: 20230622
DOI: 10.1111/pin.13321
PMID: 37036163
قاعدة البيانات: MEDLINE
الوصف
تدمد:1440-1827
DOI:10.1111/pin.13321